1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Cryptosporidiosis Global Clinical Trials Review, H2, 2014

Cryptosporidiosis Global Clinical Trials Review, H2, 2014

  • November 2014
  • -
  • Global Data
  • -
  • 54 pages

Cryptosporidiosis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Cryptosporidiosis Global Clinical Trials Review, H2, 2014" provides data on the Cryptosporidiosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cryptosporidiosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cryptosporidiosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Cryptosporidiosis Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 5
Cryptosporidiosis 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Middle East and Africa 11
Clinical Trials by G7 Countries: Proportion of Cryptosporidiosis to Infectious Disease Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Clinical Trials by End Point Status 18
Unaccomplished Trials of Cryptosporidiosis 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Top Companies Participating in Cryptosporidiosis Therapeutics Clinical Trials 23
Prominent Drugs 24
Clinical Trial Profiles 25
Clinical Trial Overview of Top Companies 25
Romark Laboratories, L.C. 25
Clinical Trial Overview of Romark Laboratories, L.C. 25
Sanofi 26
Clinical Trial Overview of Sanofi 26
Pfizer Inc. 27
Clinical Trial Overview of Pfizer Inc. 27
Johnson and Johnson 28
Clinical Trial Overview of Johnson and Johnson 28
Univax Biologics Inc 29
Clinical Trial Overview of Univax Biologics Inc 29
Stolle Milk Biologics, Inc. 30
Clinical Trial Overview of Stolle Milk Biologics, Inc. 30
Rhone-Poulenc Rorer (SA) (Pty) Ltd 31
Clinical Trial Overview of Rhone-Poulenc Rorer (SA) (Pty) Ltd 31
AbbVie Inc. 32
Clinical Trial Overview of AbbVie Inc. 32
Clinical Trial Overview of Top Institutes / Government 33
The National Institute of Allergy and Infectious Diseases 33
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 33
Nagoya University Graduate School of Medicine 34
Clinical Trial Overview of Nagoya University Graduate School of Medicine 34
Cornell University 35
Clinical Trial Overview of Cornell University 35
Tufts University 36
Clinical Trial Overview of Tufts University 36
Five Key Clinical Profiles 37
Appendix 52
Abbreviations 52
Definitions 52
Research Methodology 53
Secondary Research 53
About GlobalData 54
Contact Us 54
Disclaimer 54
Source 54

List of Tables
Cryptosporidiosis Therapeutics, Global, Clinical Trials by Region, 2014* 6
Cryptosporidiosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Cryptosporidiosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Cryptosporidiosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Cryptosporidiosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 10
Cryptosporidiosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 11
Proportion of Cryptosporidiosis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 12
Cryptosporidiosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Cryptosporidiosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Cryptosporidiosis Therapeutics, Global, Clinical Trials by Phase, 2014* 15
Cryptosporidiosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 16
Cryptosporidiosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
Cryptosporidiosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 18
Cryptosporidiosis Therapeutics, Global, Terminated Clinical Trials, 2014* 19
Cryptosporidiosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
Cryptosporidiosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 21
Cryptosporidiosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22
Cryptosporidiosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23
Cryptosporidiosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Romark Laboratories, L.C., 2014* 25
Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 26
Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 27
Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2014* 28
Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Univax Biologics Inc, 2014* 29
Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Stolle Milk Biologics, Inc., 2014* 30
Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rhone-Poulenc Rorer (SA) (Pty) Ltd, 2014* 31
Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2014* 32
Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 33
Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagoya University Graduate School of Medicine, 2014* 34
Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cornell University, 2014* 35
Cryptosporidiosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tufts University, 2014* 36

List of Figures

Cryptosporidiosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Cryptosporidiosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Cryptosporidiosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Cryptosporidiosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Cryptosporidiosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 11
Proportion of Cryptosporidiosis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 12
Cryptosporidiosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Cryptosporidiosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Cryptosporidiosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 15
Cryptosporidiosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 16
Cryptosporidiosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
Cryptosporidiosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 18
Cryptosporidiosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
Cryptosporidiosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 21
Cryptosporidiosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22
Cryptosporidiosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23
GlobalData Methodology 53

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.